Development of chitosan/polyethylene vinyl acetate co-matrix: controlled release of aspirin-heparin for preventing cardiovascular thrombosis
- 31 March 1997
- journal article
- Published by Elsevier in Biomaterials
- Vol. 18 (5) , 375-381
- https://doi.org/10.1016/s0142-9612(96)00131-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Modification of layered atelocollagen by ultraviolet irradiation and chemical cross-linking: structure stability and mechanical propertiesBiomaterials, 1994
- Chitosan matrix for oral sustained delivery of ampicillinBiomaterials, 1993
- Biological activity of chitosan: ultrastructural studyBiomaterials, 1988
- Magnetically enhanced insulin release in diabetic ratsJournal of Biomedical Materials Research, 1987
- Macrophage activation with multi‐porous beads prepared from partially deacetylated chitinJournal of Biomedical Materials Research, 1986
- Inhibition of Platelet Adhesion to Glow Discharge Modified SurfacesJournal of Biomaterials Applications, 1986
- Structural relevance of adsorbed aminosugars on polycarbonate-antithrombogenicityThrombosis Research, 1984
- On the mechanism of enhanced thromboresistance of polymeric materials in the presence of heparinBiomaterials, 1983
- Colorimetric method for the assay of heparin content in immobilized heparin preparationsAnalytical Biochemistry, 1980
- INVITED REVIEW POLYMERIC DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASEChemical Engineering Communications, 1980